Paul Loholm

Compounding for Pediatric Patients
UAN: 0201-9999-22-006-L07-P/T
Lisa D. Ashworth, BS Pharm, RPh, BCSCP, FACA
System Compounding Specialist and Clinical Pharmacist,  Children’s Health System of Texas
This session is sponsored by Xenex Labs, Inc.

Activity Description: This session will explain some challenges in choosing an API, excipient, vehicle, and flavorings for a compounded formulation. Vehicles and excipients can affect a patient clinically – balancing their potential adverse effects is important. Stability and storage needs, especially for chronic medications has to be considered. This presentation will lead to better patient care by understanding how the components in a compounded formulation can affect a patient clinically.

The intended audience is compounding pharmacists and technicians who may compound for pediatric patients.

Learning Objectives for Pharmacists & Pharmacy Technicians:
1. Explain some challenges in choosing an API, excipient, vehicle, and flavorings for a compounded formulation.
2. Discuss some adverse effects that can occur from vehicles, excipients, and flavorings that have the potential to affect a patient clinically.
3. Describe the differences in potency and texture that may occur in using a commercial product or a raw material as the API.

Dr. Diego Marro

Equine Pharmacology
UAN: 0201-9999-22-008-L08-P/T
Sue Hudson Duran, RPh,MS,PhD, DICVP, FSVHP,FACVP
GMP Pharmacist/Professor Emeritus, Auburn University/Auburn Equine SPP

Activity Description: Veterinarians would practice equine medicine depend on pharmacists that are training in proper preparation, compounding and dispensing medication. The pharmacists need to be aware of medications in horses that may be toxic. The practicing pharmacists needs to know the difficulties of dosing horses in order to prepare safe and efficacious medication. Drug interactions ae also a skill that pharmacists may contribute for the veterinarian as many horses may be on polypharmacy . Safe handling of equine medications will be discusses as well as an occupational safety step to protect your employees.

At the completion of this activity, the participant will be able to:
1. Review the anatomy and physiology of the horse
2. Discuss absorption differences in the equine
3. Review therapy of common equine diseases
4. Identify improved knowledge of therapy and limits of absorption in a horse
5. Define safe handling of equine medications to prevent side effects

PK/PD Considerations in Developing Anesthetic Plans for Critically Ill Patients using Partial Intravenous Anesthesia (PIVA) and Total Intravenous Anesthesia (TIVA)
UAN: 0201- 9999-22-009-L01-P/T
Tereza Stastny, MD, DVM, DACVECC
Veterinary Critical Care Specialist, Arizona Veterinary Emergency and Critical Care

Activity Description: Understanding PK/PD considerations of available anesthetic agents are necessary in order to optimize critically ill patients’ (ASA status of 3 +) anesthetic plans. Partial intravenous anesthesia technique (PIVA) is used to lower the inspired concentration of an inhalational anesthetic by concurrent use of injectable drugs. This technique reduces the incidence of undesirable side effects and provides superior quality of anesthesia and analgesia. Total Intravenous Anesthesia (TIVA) is used to eliminate the need for inhalational anesthetic altogether and further reduces risk of undesirable side-effects. Additionally, close monitoring by well-trained staff, preoperative optimization of the patient’s condition, and a chronological plan for intraoperative management, anticipation of complications, and a plan for postoperative care should all be included when preparing to anesthetize a critically ill patient.

This presentation will focus on the PK/PD considerations of available veterinary drugs and implementing PIVA and TIVA in various clinical scenarios.

Learning Objectives:
1. Understand PK/PD considerations of anesthetic agents relevant to critically ill patients
a. Define minimum alveolar concentration (MAC)
i. Identify MAC sparing agents and conditions
b. Explain Blood Gas Partition Coefficient (BGPC)
i. Identify inhalants induction rate based on their BGPCs
2. Define partial intravenous anesthesia technique (PIVA)
a. Understand PK considerations of CRIs
b. Identify common drugs used for PIVA
c. Understand how to calculate PIVA CRI doses
3. Define total intravenous anesthesia technique (TIVA)
a. Identify common drugs used for TIVA
4. Practice creating anesthetic protocols for critically ill cases

You Need to Treat What? Meeting the Unique Pharmacy Needs of Zoo Animals
Ryan Colburn, DVM
Veterinarian, John Ball Zoo

Thomas A. Magnifico RPh, FACA, FACVP,
Pharmacist/Veterinary Specialist, Keystone Pharmacy

Activity Description: The goal of this presentation is to share the unique partnership that often exists between zoo veterinarians and pharmacists as we work together to find creative ways to treat a whole array of different species. A variety of cases will be presented to illustrate the wide array of challenges that zoological species can present to their care team and the many ways that pharmacists can identify unique solutions to assist veterinarians in meeting those challenges. This presentation will seek to give both pharmacists and pharmacy technicians a greater appreciation of strategies that can be used to meet the needs of some of the world’s most unique patients.

Vitamins Fact or Fiction: Functionally Using Nutrients to Impact Positive Patient Outcomes
UAN: 0201-9999-22-011-L01-P/T
Jeff Robins RPh, FAARFM, FACA, ABAAHP
Summit Functional Consulting
Consultant/Functional Pharmacist

Activity Description: Many of our patients eat the standard American diet (SAD). Along with poor daily diet, most of our patients are taking medications that cause drug induced nutritional deficiencies. Our patients are at risk for further health degradation due to their nutritional status. Jeff will help you understand how to pick nutritional products that are efficacious in your patients. You will learn how to meet your patient’s nutritional needs generally, and for specific common ailments and disease states. Not only does this type of practice offer a sustainable profit model, your practice will set itself apart from the competition by giving in depth nutritional care to your patients.

Learning Objectives:
1. Identify if the produced vegetables and fruits in the United States are less nutritious now than in 1950.
2. Recall the main nutrients Americans are at risk of being deficient in?
3. Write down the dosages for the top five nutrients each pharmacist thinks would be most beneficial to their patients.
4. Compile a strategy to talk to your patients

Lara Zakaria